Diabetic Ketoacidosis Associated With Orlistat Treatment
Authors:
- 1 March 2001
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 24 (3) , 602
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Drug points: Orlistat associated with hypertensionBMJ, 2000
- Orlistat, a New Lipase Inhibitor for the Management of ObesityPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2000
- OrlistatDrugs, 1999
- NOVEL LIPID-LOWERING PROPERTIES OF VACCINIUM MYRTILLUS L. LEAVES, A TRADITIONAL ANTIDIABETIC TREATMENT, IN SEVERAL MODELS OF RAT DYSLIPIDAEMIA: A COMPARISON WITH CIPROFIBRATEThrombosis Research, 1996
- Antidiabetic plants and their active constituentsPhytomedicine, 1995
- The effect of the gastrointestinal lipase inhibitor, orlistat, on serum lipids and lipoproteins in patients with primary hyperlipidaemiaEuropean Journal of Clinical Pharmacology, 1994
- Erythromycin and other macrolides as prokinetic agentsGastroenterology, 1993
- A review of natural products and plants as potential antidiabetic drugsJournal of Ethnopharmacology, 1989
- Evaluation of the Sterility and Stability of Insulin from Multidose Vials Used for Prolonged PeriodsInfection Control, 1985
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985